+5,403.1%
NVDA vs THC
+1,458.3%
+3,944.9%
-66.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -14.0% | -0.2% | -13.9% | -14.0% |
| 7D | -22.9% | -8.0% | -14.9% | -21.7% |
| 30D | -43.4% | -2.2% | -41.2% | -43.3% |
| 3M | -42.0% | -3.5% | -38.6% | -41.9% |
| 6M | -43.7% | +40.4% | -84.1% | -48.1% |
| YTD | -32.5% | +32.4% | -65.0% | -37.5% |
| 1Y | -30.3% | +41.0% | -71.3% | -36.4% |
| 3Y | +149.8% | +305.2% | -155.5% | +77.9% |
| 5Y | +282.2% | +239.8% | +42.4% | +174.5% |
| All | +5,403.1% | +1,458.3% | +3,944.9% | +2,869.6% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling